loading page

High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic
  • +5
  • Jean Michel Mansuy,
  • Martial Kenfack,
  • Suzanne Burel,
  • Candice Pollani,
  • Marlise Lebobo,
  • Célestin Ekaé,
  • Antoine Berry,
  • Jacques Izopet
Jean Michel Mansuy
University Hospital Centre Toulouse

Corresponding Author:mansuy.jm@chu-toulouse.fr

Author Profile
Martial Kenfack
Health Care Center of the CASS
Author Profile
Suzanne Burel
CHU Toulouse Pôle biologie
Author Profile
Candice Pollani
CHU Toulouse Pôle biologie
Author Profile
Marlise Lebobo
Health Care Center of the CASS
Author Profile
Célestin Ekaé
Health Care Center of the CASS
Author Profile
Antoine Berry
University Hospital Centre Toulouse
Author Profile
Jacques Izopet
University Hospital Centre Toulouse
Author Profile

Abstract

We found a seroprevalence of anti-SARS-CoV-2 IgG of 77% in a population of Cameroonian pregnant women sampled 14 months after the start of the COVID-19 pandemic. This high exposure to the virus requires a rethinking of vaccine priorities in African countries. The value of vaccination against COVID-19 should be considered at the local level based on seroprevalence studies, but the expanded programme of vaccination interrupted during the pandemic should be resumed urgently.